Cargando…

Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinoma

Exploring the regulatory mechanism of PD-L1 in renal cancer is one of the key strategies to improve the response of renal cancer patients to checkpoint blockade therapy. In this study, the synergistic effect of ascorbic acid (vitamin C) supplementation and the impact of TET2 depletion on anti-PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Ding, He, Anbang, He, Shiming, Ge, Guangzhe, Wang, Shuo, Ci, Weimin, Li, Xuesong, Xia, Dan, Zhou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771844/ https://www.ncbi.nlm.nih.gov/pubmed/35173532 http://dx.doi.org/10.7150/ijbs.67329

Ejemplares similares

Construction of diagnostic and subtyping models for renal cell carcinoma by genome-wide DNA methylation profiles
por: Zhang, Jianye, et al.
Publicado: (2021)

ZFAS1: A novel vital oncogenic lncRNA in multiple human cancers
por: He, Anbang, et al.
Publicado: (2018)

MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
por: He, Anbang, et al.
Publicado: (2020)

Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer
por: Peng, Ding, et al.
Publicado: (2018)

Prognostic value of long non-coding RNA signatures in bladder cancer
por: He, Anbang, et al.
Publicado: (2019)

Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
por: Zhan, Yonghao, et al.
Publicado: (2018)

TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation
por: Chen, Zhicong, et al.
Publicado: (2019)

Correction: Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA
por: Zhan, Yonghao, et al.
Publicado: (2023)

Metabolism-Related Signature Analysis Uncovers the Prognostic and Immunotherapeutic Characteristics of Renal Cell Carcinoma
por: Zhang, Jianye, et al.
Publicado: (2022)

Cancer immunotherapies: advances and bottlenecks
por: Rui, Rui, et al.
Publicado: (2023)

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2020)

P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma
por: Wu, Yucai, et al.
Publicado: (2021)

Long non-coding RNA HNF1A-AS1 promotes proliferation and suppresses apoptosis of bladder cancer cells through upregulating Bcl-2
por: Zhan, Yonghao, et al.
Publicado: (2017)

Ascorbic acid improves parthenogenetic embryo development through TET proteins in mice
por: Gao, Wei, et al.
Publicado: (2019)

Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
por: Shenoy, N, et al.
Publicado: (2017)

High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center
por: Li, Yifan, et al.
Publicado: (2019)

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia
por: Guan, Yihong, et al.
Publicado: (2020)

Knockdown of Tet2 Inhibits the Myogenic Differentiation of Chicken Myoblasts Induced by Ascorbic Acid
por: Lu, Yinglin, et al.
Publicado: (2022)

Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2020)

Correction: Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2
por: Zhan, Yonghao, et al.
Publicado: (2023)

Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2017)

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2023)

Single‐Cell RNA‐seq Reveals a Developmental Hierarchy Super‐Imposed Over Subclonal Evolution in the Cellular Ecosystem of Prostate Cancer
por: Ge, Guangzhe, et al.
Publicado: (2022)

Engineered Split-TET2 Enzyme for Inducible Epigenetic Remodeling
por: Lee, Minjung, et al.
Publicado: (2017)

Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2023)

Tet Enzymes, Variants, and Differential Effects on Function
por: Melamed, Philippa, et al.
Publicado: (2018)

Growth Pattern of Clear Cell Renal Cell Carcinoma in Patients with Delayed Surgical Intervention: Fast Growth Rate Correlates with High Grade and May Result in Poor Prognosis
por: Zhang, Lei, et al.
Publicado: (2015)

Advances in the research of exosomes in renal cell carcinoma: from mechanisms to applications
por: Rui, Rui, et al.
Publicado: (2023)

Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis
por: Li, Yifan, et al.
Publicado: (2018)

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma
por: Fang, Dong, et al.
Publicado: (2018)

Role of TET enzymes in DNA methylation, development, and cancer
por: Rasmussen, Kasper Dindler, et al.
Publicado: (2016)

Biomimetic Iron Complex Achieves TET Enzyme Reactivity
por: Schmidl, David, et al.
Publicado: (2021)

Increased chromosomal instability characterizes metastatic renal cell carcinoma
por: Ma, Qin, et al.
Publicado: (2020)

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
por: Wagner, Samuel C, et al.
Publicado: (2014)

Restored expression levels of TET1 decrease the proliferation and migration of renal carcinoma cells
por: FAN, MIN, et al.
Publicado: (2015)

Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
por: Das, Andrew B., et al.
Publicado: (2019)

PB2166: TET ENZYMES PROTECT AGAINST FATAL LYMPHOPROLIFERATION
por: Spoeck, S., et al.
Publicado: (2022)

TLR4 predicts patient prognosis and immunotherapy efficacy in clear cell renal cell carcinoma
por: Zhang, Zhentao, et al.
Publicado: (2023)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nsmmea5a4nb8qn04gn85mchh9p